Private company
NeuroMetrix, Inc.
American surgical and medical instruments and apparatus company.
Last updated Oct 18, 2026.
Overview
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2024
55.4%Gross margin3
-289.6%Operating margin3
-257.4%Net margin3
-48.6%Revenue growth, 20243
-54.5%Return on equity3
Where the money goes
Where each dollar of revenue went, fiscal 2024
- Cost of revenue43¢$1.4M
- Research and development57¢$1.8M
Out of $3.0M in revenue.3 The company lost money this year.
Financial statements
| Fiscal year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | $16.1M4 | $9.3M5 | $7.4M6 | $8.3M7 | $8.3M8 | $5.9M3 | $3.0M3 |
| Cost of revenue | $8.7M4 | $7.0M5 | $2.1M6 | $2.3M7 | $2.5M8 | $2.0M3 | $1.4M3 |
| Gross profit | $7.4M4 | $2.2M5 | $5.2M6 | $5.9M7 | $5.8M8 | $3.9M3 | $1.7M3 |
| Research and development | $5.1M4 | $3.1M5 | $2.4M6 | $2.6M7 | $3.2M8 | $2.8M3 | $1.8M3 |
| Operating income | -$12.3M4 | -$11.5M5 | -$2.1M6 | -$2.3M7 | -$4.7M8 | -$7.2M3 | -$8.8M3 |
| Income tax | $04 | $04 | |||||
| Net income | $23.6K4 | -$3.8M5 | -$2.1M6 | -$2.3M7 | -$4.4M8 | -$6.5M3 | -$7.8M3 |
| Earnings per share | $0.034 | -$3.904 | -$0.696 | -$0.457 | -$4.978 | -$6.273 | -$3.963 |
| Earnings per share (diluted) | $0.024 | -$3.904 | -$0.696 | -$0.457 | -$4.978 | -$6.273 | -$3.963 |
| Fiscal year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Cash | $6.8M4 | $3.1M5 | $5.2M6 | $22.6M7 | $4.3M8 | $1.7M3 | $1.4M3 |
| Current assets | $11.6M4 | $5.4M5 | $7.1M6 | $24.2M7 | $24.1M8 | $20.9M3 | $15.0M3 |
| Total assets | $14.0M4 | $6.9M5 | $8.0M6 | $24.9M7 | $24.7M8 | $21.4M3 | $15.3M3 |
| Current liabilities | $6.6M4 | $3.4M5 | $2.3M6 | $1.4M7 | $1.1M8 | $1.2M3 | $1.0M3 |
| Total liabilities | $7.9M4 | $4.4M5 | $2.7M6 | $1.7M7 | $1.3M8 | $1.3M3 | $1.0M3 |
| Shareholders’ equity | $6.1M5 | $2.5M6 | $5.2M7 | $23.2M8 | $23.4M3 | $20.1M3 | $14.3M3 |
| Shares outstanding | 738.0K shares4 | 1.4M shares5 | 3.8M shares6 | 6.7M shares7 | 971.5K shares8 | 1.5M shares3 | 2.1M shares3 |
Leadership
Who has led NeuroMetrix, Inc., and when. Pick a name to see everywhere that person has worked.
Chief executive
President
Chief financial officer
Chief operating officer
2010201520202025
- Chief executive officerShai Gozani Jan 18, 2006 to now11
- PresidentShai Gozani Jan 18, 2006 to now11
- Chief financial officerThomas T. Higgins Sep 14, 2009 to now12
- Chief operating officerKrishnamurthy Balachandran Mar 13, 2012 to Apr 29, 201313
- Chief operating officerGary Gregory Mar 1, 2006 to Mar 29, 200714
Board members and other officers (18)
- Senior VP, ConsumerFrancis X. McGillin Sep 5, 2014 to Dec 30, 201915
- Sr. VP and GM, InternationalKrishnamurthy Balachandran May 21, 2010 to Feb 3, 201116
- Sr. VP, Global SalesWalter Christensen May 6, 2009 to Feb 2, 201117
- Principal Finance&Acct.officerJoseph A. Calo Jul 25, 2008 to Feb 17, 200918
- Chief Operationg OfficerGary Gregory Jan 17, 2006 to Apr 3, 200819
- Snr VP Information TechnologyGuy Daniello Jan 17, 2006 to Apr 28, 201420
- Board memberThomas T. Higgins Feb 5, 2025 to now21
- Board memberJoshua Horowitz Apr 22, 2024 to now22
- Board memberFluegel M. Bradley Jul 6, 2022 to now23
- Board memberAvermaete David Van Oct 2, 2013 to now24
- Board memberNancy E. Katz Dec 17, 2010 to now25
- Board memberW. Mark Lortz Feb 17, 2009 to Feb 17, 200926
- Board memberTimothy R. Surgenor Apr 3, 2009 to May 2, 201827
- Board memberJonathan T. Lord Md. Jan 3, 2006 to Jan 3, 200628
- Board memberAllen J. Hinkle Jan 17, 2006 to Jun 1, 201629
- Board memberShai Gozani Jan 18, 2006 to now11
- Board memberCharles R. Lamantia Feb 8, 2006 to Feb 3, 201130
- Board memberDavid Goodman Mar 1, 2006 to now31
Timeline
- Jan 18, 2006New chief executive Shai Gozani becomes CEO11
Filings
190 filings to the SEC since October 2021: 5 annual reports, 10 quarterly reports, 32 major events, 69 insider forms, 11 large holders, 63 other. The latest 20:
- Aug 13, 2025SCHEDULE 13G/A EDGAR
- May 12, 202515-12G EDGAR
- May 5, 2025EFFECT EDGAR
- May 5, 2025EFFECT EDGAR
- May 5, 2025EFFECT EDGAR
- May 5, 2025EFFECT EDGAR
- May 5, 2025EFFECT EDGAR
- May 5, 2025EFFECT EDGAR
- May 5, 2025EFFECT EDGAR
- May 5, 2025EFFECT EDGAR
- May 5, 2025EFFECT EDGAR
- May 5, 20254 EDGAR
- May 5, 20254 EDGAR
- May 5, 20254 EDGAR
- May 5, 20254 EDGAR
- May 5, 20254 EDGAR
- May 5, 20254 EDGAR
- May 2, 2025S-8 POS EDGAR
- May 2, 2025S-8 POS EDGAR
- May 2, 2025S-8 POS EDGAR
The 190 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last three years, summarized. The full record is on SEC EDGAR.
Insider trades and holders
Large holders
Investors who own more than 5% must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively. 11 such filings since October 2021, the latest 10:
- Aug 13, 2025SCHEDULE 13G/A
- Feb 13, 2025SCHEDULE 13G/A
- Dec 19, 2024SCHEDULE 13D/A
- Sep 27, 2024SC 13G
- Apr 1, 2024SCHEDULE 13D/A
- Mar 4, 2024SC 13D/A
- Feb 27, 2024SC 13D
- Feb 26, 2024SC 13D
- Feb 20, 2024SCHEDULE 13G
- Feb 13, 2023SC 13G/A
From Forms 4 and Schedules 13D and 13G filed with the SEC.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11SEC EDGARShai Gozani, Chief executive officer
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21SEC EDGARThomas T. Higgins, Board member
- 22SEC EDGARJoshua Horowitz, Board member
- 23SEC EDGARFluegel M. Bradley, Board member
- 24SEC EDGARAvermaete David Van, Board member
- 25SEC EDGARNancy E. Katz, Board member
- 26SEC EDGARW. Mark Lortz, Board member
- 27SEC EDGARTimothy R. Surgenor, Board member
- 28SEC EDGARJonathan T. Lord Md., Board member
- 29SEC EDGARAllen J. Hinkle, Board member
- 30SEC EDGARCharles R. Lamantia, Board member
- 31SEC EDGARDavid Goodman, Board member